Skip to content
Logo text: ISPOR Improving healthcare decisions

Health Technology Assessment Central

The HTA Resource Center for Informing Healthcare Decisions

  • Home
  • What Is HTA?
  • HTA News and Events
  • Resource Library
  • Governance
  • Policy Interchange
  • Training and Development
« Back to ISPOR.org

News

CVS sets a cost-effectiveness threshold for health plan coverage of most new drugs

August 24, 2018

https://www.statnews.com/pharmalot/2018/08/14/cvs-cost-effectiveness-new-drugs/

Posted in: Uncategorized

Post navigation

← Irish HTA Official Calls for All New Patients to Start With Biosimilars
Professor says HSE should ‘take seriously’ cheaper medicines →

News

The new definition of HTA: A milestone in international collaboration
Impact of a Global Pandemic on Health Technology Assessment
NEW HTAi – ISPOR Joint Deliberative Processes for HTA Task Force
Strategic collaboration announced by NICE and Health Technology Wales
NICE and LSE announce new Executive MSc in Evaluation of Health Care Interventions and Outcomes degree program, starting in April 2020
Why HTA and Pooled Purchasing Must Be at the Heart of Global Health Transitions
Health Technology Assessment Around the World: Broadening the Understanding of Cross-Country Differences
Ghana’s HTA agenda and UHC, what difference could HTA make?
AMCP releases the AMCP Format for Formulary Submissions, version 4.1
The ‘Top 10’ Challenges for Health Technology Assessment: INAHTA Viewpoint

Twitter

Tweets about #HTA

#HTA

PeterNeumann11Peter Neumann@PeterNeumann11·
10h

.@TuftsCEVR's Center for Enhanced Value Assessment (CEVA) is pleased to partner w/ @NHCouncil to develop good–practice recommendations to help researchers develop more #patient-centered value & #HTA assessments.
https://tinyurl.com/3f5vsh4z @umsop @PhRMAfoundation @tara_lavelle #HEOR

Reply on Twitter 1392238629846667267Retweet on Twitter 13922386298466672673Like on Twitter 13922386298466672672Twitter 1392238629846667267
HTAiOrgHTAi@HTAiOrg·
10h

Did you know our Public Health Interest Group has been triggering innovative public-private partnerships through outreach initiatives?

Learn more: https://buff.ly/3oc1M1U

#InterestGroups #PublicHealth #HTA #HealthTech

Reply on Twitter 1392238571491401730Retweet on Twitter 1392238571491401730Like on Twitter 13922385714914017302Twitter 1392238571491401730
PeterNeumann11Peter Neumann@PeterNeumann11·
11h

.@TuftsCEVR and our Center for Enhanced Value Assessment (CEVA) is pleased to partner w/
@NHCouncil to develop good–practice recommendations to help researchers develop more patient-centered value & #HTA assessments. https://tinyurl.com/rc53pswm @umsop @PhRMAfoundation @tara_lavelle

Reply on Twitter 1392224223406530562Retweet on Twitter 13922242234065305621Like on Twitter 13922242234065305625Twitter 1392224223406530562
Load More...
Privacy Policy | Disclaimer
Copyright © 2021 ISPOR – The Professional Society for Health Economics and Outcomes Research